Navigation Links
BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award
Date:7/11/2014

BostonThe American Society for Bone and Mineral Research awarded Michael F. Holick, PhD, MD, of Boston University School of Medicine (BUSM), with the 2014 Louis V. Avioli Award. Holick, a professor of medicine, physiology and biophysics at BUSM, is internationally known for revolutionizing the understanding of vitamin D and its role in disease prevention.

The award honors a member of the American Society for Bone and Mineral Research (ASBMR) for fundamental contributions to bone and mineral basic research. It is named for ASBMR's first president and founding member, Louis Avioli, MD, who was one of the world's leading medical authorities on osteoporosis and calcium metabolism. Holick will be recognized at the ASBMR Annual Meeting in September by the society's president, Roberto Civitelli, MD.

"I am honored to receive this award named for my very close friend and trusted colleague," said Holick. "I collaborated with Louis on multiple occasions, and he provided samples of blood from his patients that I used to identify, for the first time, 25-hydroxyvitamin D3 in human blood. This discovery led me to receiving a masters' degree in biochemistry."

Holick has revolutionized the field of vitamin D research with the identification of 1,25-dihydroxyvitamin D3, for which he received his PhD degree, which led to therapies for metabolic bone diseases, hypocalcemic disorders and psoriasis. His work raised awareness of the vitamin D deficiency epidemic and its role in causing metabolic bone disease and osteoporosis and increasing the risk of autoimmune diseases, type 2 diabetes, infectious diseases, heart disease and common deadly cancers. He has helped develop guidelines for the prevention and treatment of vitamin D deficiency with vitamin D supplementation and sensible sun exposure.

The author of more than 500 publications, Holick received his doctorate in biochemistry and attended medical school at the University of Wisconsin before completing a residency in medicine at Massachusetts General Hospital.


'/>"/>

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Related biology news :

1. AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
2. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
3. Michael Barnett of Boston College named Professor of the Year for Massachusetts
4. Researchers and company from Luxembourg awarded a grant from Michael J. Fox Foundation
5. Brupbacher Prize goes to cancer researcher Michael Karin
6. Anne Glover and Sir Michael Stratton to meet the press at The EMBO Meeting 2013 in Amsterdam
7. EyeLock Appoints Michael Fiorito Vice President of Enterprise Accounts
8. TGen Dr. Michael Barrett awarded $200,000 grant at national cancer conference in San Diego
9. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
10. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
11. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2017)... Feb. 6, 2017 According to Acuity ... driving border authorities to continue to embrace biometric ... are 2143 Automated Border Control (ABC) eGates and ... at more than 163 ports of entry across ... 2016 achieving a combined CAGR of 37%. APC ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
Breaking Biology News(10 mins):
(Date:2/16/2017)...  ArmaGen, Inc., a privately held biotechnology company ... neurological disorders, today reported preliminary evidence of cognitive ... investigational therapy for the treatment of Hurler and ... or MPS I). The initial results from an ... at the 13 th annual WORLD Symposium ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)... SAN DIEGO , Feb. 16, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... $5 million Series 1a financing and entered into ... Bank (SVB).  Dermata intends to use the capital ... of making major advancements in the treatment of ...
Breaking Biology Technology: